METAIAM wins first place at NYC cross-border startup competition
METAIAM took first place at the 2026 NYC Cross-Border US Startup Competition on Oct. 10 at NYU’s Vanderbilt Hall. The event spotlighted nine AI, life sciences and healthcare ventures and drew entrepreneurs, investors and industry professionals to New York City.
Why it matters: - The competition highlighted early-stage ventures building tools for enterprise security, healthcare and advanced sensing. - METAIAM’s win puts a spotlight on technology designed to verify that a real person is behind high-risk enterprise approvals, a growing issue as autonomous AI systems and deepfakes spread. - The event also connected founders with investors and industry participants in New York City.
What happened: - METAIAM won first place at the 2026 NYC Cross-Border US Startup Competition on Oct. 10 at New York University’s Vanderbilt Hall. - Orbitour AI placed second. - Thread Bioscience and medara tied for third. - Each of the four top teams also received an Excellence Award. - The top teams were represented by David Tang of METAIAM, Zihao Zhang of Orbitour AI, Craig Serio of Thread Bioscience and Kendra Batchelder of medara. - NYU CSSA and CLSA organized the competition. - The program included startup pitches, keynote addresses, a panel discussion and an awards ceremony.
The details: - METAIAM develops technology to verify that a real person is behind high-risk enterprise authorizations. - Orbitour AI combines an AI sales assistant with interactive, photorealistic 3D representations of venues. - Thread Bioscience is developing CultureStat, a point-of-care bacterial testing platform for urinary tract infections. - medara is building AI tools for breast cancer screening and risk assessment. - Five additional ventures received Outstanding Project recognition: Aident AI, Qnity, SATORI, Haystack Medical and Miora Health. - Aident AI connects AI agents with tools, accounts and data to support business workflows. - Qnity is developing quantum-electrochemical sensors for molecular screening. - SATORI combines AI and synthetic biology to discover and produce bioingredients. - Haystack Medical is building a microneedle platform for inner-ear fluid sampling and targeted drug delivery. - Miora Health combines at-home microbiome testing with AI to assess the risk of pregnancy complications during the first trimester. - The competition recognized nine projects in total.
Between the lines: - The mix of winners suggests investor interest remains strong across AI infrastructure, healthcare diagnostics and biotech-enabled tools. - The emphasis on cross-border collaboration points to a broader goal of linking founders with resources, mentors and market access beyond a single startup pitch event. - Keynotes and panel programming added a networking and commercialization layer to the competition, not just a prize-awards format.
What's next: - NCUSC will continue to serve as a showcase for emerging ventures and a venue for founder-investor connections. - The winning teams may use the recognition to support fundraising, partnership outreach and market entry conversations. - NYU CSSA and CLSA will keep using the event format to support cross-border collaboration and professional networking.
The bottom line: - METAIAM led a field of nine recognized ventures in a competition that blended startup pitching, investor access and cross-border business networking.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Bay State Culture Daily
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.